Latest medical news · page 253

The latest headlines across every section, pulled from official and open-access sources.

NCI Cancer Currents · May 4, 2026

Your NCI: Top Priorities from AACR 2026

NCI Director Dr. Anthony Letai shares his reflections on this year’s AACR Annual Meeting, including science that stood out and NCI’s leading priorities.

WHO · May 4, 2026

Joint call by the President of the ICRC, the Director-General of WHO and the International President of MSF

Ten years ago, the UN Security Council unanimously adopted Resolution 2286 on health care in armed conflicts. The situation is even worse compared to 10 years ago. Today, we mark not an achievement – we mark a failure. As violence affecting medical facilities, transport and personnel continues unabated, the harm this resolution sought to prevent has not diminished. It has continued and, in many contexts, intensified. As the heads of the International Committee of the Red Cross (ICRC), the World Health Organization (WHO), and Médecins Sans Frontières (MSF), we join others in the international…

NHS England · May 3, 2026

‘1-minute’ immunotherapy jab rolled out on NHS for tens of thousands with cancer

Tens of thousands of patients could benefit from a ‘rapid’ new immunotherapy jab on the NHS for over a dozen different cancers, which can be given in just 60 seconds. The NHS is rolling out a new injectable form of pembrolizumab (Keytruda) which can slash the time the treatment takes by up to 90%, to […]

WHO · May 1, 2026

WHO Member States agree to extend negotiations on Pathogen Access and Benefit Sharing annex

Member States of the World Health Organization (WHO) have progressed work on the Pathogen Access and Benefit Sharing (PABS) annex, a key part of the WHO Pandemic Agreement, and today agreed additional time was needed to finalize the framework for ensuring a better, more equitable, response to future pandemics. Countries today ended the resumed session of the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement in Geneva, focused on the PABS system. The outcome of this work will be presented to the Seventy-ninth World Health Assembly (WHA) later this month…

FDA Newsroom · May 1, 2026

FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug

FDA is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

Drugs@FDA · May 1, 2026

FDA approves Jakafi Xr (ruxolitinib phosphate)

Original new drug approval. tablet, extended release, oral. Sponsor: Incyte Corp

NHS England · Apr 30, 2026

1,000 NHS staff call Martha’s Rule helplines in first 18 months

More than 1,000 NHS staff across England have used Martha’s Rule helplines to help identify rapid deterioration of a patient’s condition in the first 18 months of the scheme, new figures show. Latest NHS England data shows that between September 2024 and February 2026, 1,781 calls were made by hospital staff to Martha’s Rule helplines […]

FDA Newsroom · Apr 30, 2026

FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Dementia

The U.S. Food and Drug Administration today approved an expanded use for Auvelity (dextromethorphan hydrobromide and bupropion hydrochloride) extended-release tablets to treat agitation associated with dementia due to Alzheimer’s disease in adults.

CDC MMWR · Apr 30, 2026

Notes from the Field: Increase in Eastern Equine Encephalitis Virus Activity - Vermont, 2023-2024

This report describes an increase in eastern equine encephalitis in northern Vermont during 2023-2024.

CDC MMWR · Apr 30, 2026

Large Tuberculosis Outbreaks - United States, 2017-2023

This report describes 50 large tuberculosis outbreaks in 23 states during 2017-2023.

FDA Newsroom · Apr 30, 2026

FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List

FDA is proposing to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list, finding no clinical need for outsourcing facilities to compound these drugs from bulk substances.

AFP Podcast (AAFP) · Apr 30, 2026

Episode 252 | April 2026 | Part 2 American Family Physician

Heat related illness (2:00), graduate medical education funding and primary care (5:40), foreign body ingestion in children (7:40), fall prevention (11:40), chronic constipation (13:20), and oral corticosteroids in children (15:20).

NEJM This Week · Apr 29, 2026

NEJM This Week — April 30, 2026

This week, we feature advances in targeted therapy for HER2-mutant lung cancer, interventions to reduce maternal infection, an emerging treatment for hemophilia A, and a new diagnostic test for tuberculosis. We review Barrett’s esophagus and follow a case of systemic illness with kidney failure. Perspectives address GLP-1 drugs and eating disorders, directed blood donation, generic drug safety, and an in-flight medical emergency.

FDA Newsroom · Apr 29, 2026

FDA Releases Results from Largest-Ever Testing of Infant Formula in the U.S.

FDA announces results from the largest and most rigorous examination ever conducted focused on chemical contaminants in infant formula available on the U.S. market.